Hostname: page-component-76d6cb85b7-rxvq6 Total loading time: 0 Render date: 2026-07-14T15:17:07.809Z Has data issue: false hasContentIssue false
  • English
  • Français

Recurrent respiratory papillomatosis in children: coblation versus microdebrider

Published online by Cambridge University Press:  16 June 2025

G. McNally Open the ORCID record for G. McNally [Opens in a new window] ,
R. Mason  and
N. Bateman
G. McNally*
Affiliation:
Ear, Nose and Throat, Department of Paediatric Otorhinolaryngology, Royal Manchester Children’s Hospital, Manchester, UK
R. Mason
Affiliation:
Ear, Nose and Throat, Department of Paediatric Otorhinolaryngology, Royal Manchester Children’s Hospital, Manchester, UK
N. Bateman
Affiliation:
Ear, Nose and Throat, Department of Paediatric Otorhinolaryngology, Royal Manchester Children’s Hospital, Manchester, UK
*
Corresponding author: G. McNally; Email: gem060@doctors.org.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

Recurrent respiratory papillomatosis is a benign disease caused by human papillomavirus that often requires frequent surgical intervention. In the UK, microdebridement is the most common technique compared to 3.3 per cent of procedures performed with coblation. This is the first study to compare the efficacy and safety profile of microdebriders versus coblation in children.

Methods

Demographic data and surgical outcomes were collected retrospectively for all children with recurrent respiratory papillomatosis over an eight-year period.

Results

Seventeen children with recurrent respiratory papillomatosis underwent a total of three hundred operations, including 182 coblation (60.7 per cent) and 113 microdebrider procedures (37.7 per cent). The complication rate was 3.8 per cent for coblation and 7.1 per cent for microdebridement (p = 0.22). There was no significant difference in the time interval between coblation and microdebrider procedures (p = 0.21).

Conclusion

In children with recurrent respiratory papillomatosis, this study demonstrated a comparable efficacy and safety profile for surgical intervention with coblation versus the currently favoured microdebrider technique.

Keywords

LarynxPapillomatosisPaediatric airwaysStridorVoice

Information

Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 139 , Issue 9 , September 2025 , pp. 834 - 837
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Donne, AJ, Keltie, K, Cole, H, Sims, AJ, Patrick, H, Powell, S. Prevalence and management of recurrent respiratory papillomatosis (RRP) in the UK: cross-sectional study. Clin Otolaryngol 2017;42:86–91CrossRefGoogle ScholarPubMed
Benedict, JJ, Derkay, CS. Recurrent respiratory papillomatosis: A 2020 perspective. Laryngoscope Investig Otolaryngol 2021;6:340–5CrossRefGoogle ScholarPubMed
The National Institute for Health and Care Excellence. Intervention Procedure Guidance: Radiofrequency cold ablation for respiratory papillomatosis [IPG434]. In: https://www.nice.org.uk/guidance/ipg434/chapter/2-the-procedure [25 July 2024]Google Scholar
Rachimandou, A, Modayil, PC. Coblation resection of paediatric laryngeal papilloma. J Laryngol Otol 2011;125:873–6CrossRefGoogle Scholar
Zhou, C, Sun, B, Wang, F, Dai, Z, Han, Z, Han, J, et al. Coblation plus photodynamic therapy (PDT) for the treatment of juvenile onset laryngeal papillomatosis: case reports. World J Surg Oncol 2014;12:275CrossRefGoogle ScholarPubMed
El Achkar, VNR, Duarte, A, Carlos, R, Leon, JE, Ribeiro-Silva, A, Pignatari, SSN, et al. Histopathological features of juvenile-onset laryngeal papillomatosis related to severity. Head Neck 2019;41:1412–17CrossRefGoogle ScholarPubMed
Kupfer, RA, Çadalli Tatar, E, Barry, JO, Allen, CT, Merati, AL. Anatomic Derkay score is associated with voice handicap in laryngeal papillomatosis in adults. Otolaryngol Head Neck Surg 2016;154:689–92CrossRefGoogle ScholarPubMed
Buchinsky, FJ, Valentino, WL, Ruszkay, N, Powell, E, Derkay, CS, Seedat, RY, et al. Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis. PLoS One 2019;14:e0216697CrossRefGoogle Scholar
Xi, Y, Wang, H, Wang, W, Wang, X, Zhang, J, Zhao, J, et al. Risk factors for aggressive recurrent respiratory papillomatosis in Chinese juvenile patients. Acta Otolaryngol 2020;140:779–84CrossRefGoogle ScholarPubMed
Awad, R, Shamil, E, Aymat-Torrente, A, Gibbins, N, Harris, S. Management of laryngeal papillomatosis using coblation: another option of surgical intervention. Eur Arch Otorhinolaryngol 2019;276:793–800CrossRefGoogle ScholarPubMed
Hao, F, Yue, L, Yin, X, Wang, X, Shan, C. Low-temperature radiofrequency coblation reduces treatment interval and post-operative pain of laryngotracheal recurrent respiratory papillomatosis. Biosci Rep 2020;40:BSR20192005CrossRefGoogle ScholarPubMed
Carney, AS, Evans, AS, Mirza, S, Psaltis, A. Radiofrequency coblation for treatment of advanced laryngotracheal recurrent respiratory papillomatosis. J Laryngol Otol 2010;124:510–4CrossRefGoogle ScholarPubMed
Hock, K, Kennedy, A, Howell, R, Friedman, A, de Alarcon, A, Khosla, S. Surgery and adjuvant therapy improve Derkay scores in adult and pediatric respiratory papillomatosis. Laryngoscope 2022;132:2420–6CrossRefGoogle ScholarPubMed
Hester, RP, Derkay, CS, Burke, BL, Lawson, ML. Reliability of a staging assessment system for recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2003;67:505–9CrossRefGoogle ScholarPubMed
Rosenberg, T, Philipsen, BB, Mehlum, CS, Dyrvig, AK, Wehberg, S, Chirila, M, et al. Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis. J Infect Dis 2019;219:1016–25CrossRefGoogle ScholarPubMed
Park, I, Carbone, S, Preciado, D. Systematic review of the use of human papillomavirus vaccine as adjuvant therapy for juvenile-onset recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 2022;162:111314CrossRefGoogle ScholarPubMed
Novakovic, D, Cheng, ATL, Zurynski, Y, Booy, R, Walker, PJ, Berkowitz, R, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis 2018;217:208–12Google ScholarPubMed
British Laryngological Association. Position Statement: Gardasil. In: https://www.britishlaryngological.org/news/position-statement-gardasil [21 July 2024]Google Scholar